High-risk personal networks and syringe sharing as risk factors for HIV infection among new drug injectors

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 11, Issue 5, 1996, Pages 499-509

  Neaigus, Alan ^a   Friedman, Samuel R ^a   Jose, Benny ^a   Goldstein, Marjorie F ^a   Curtis, Richard ^a   Ildefonso, Gilbert ^a   Des Jarlais, Don C ^b  

^a NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

Drug injectors; HIV, Risk factors; IDUs; Networks; New injectors; Prevalence; Risk networks; Social networks; Syringe sharing

Indexed keywords

ADULT; ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INFECTION RISK; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEROEPIDEMIOLOGY; SYRINGE;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 0029928470     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199604150-00011     Document Type: Article

References (46)

1. Des Jarlais DC, Casriel C, Friedman SR, Rosenblum A. AIDS and the transition to illicit drug injection: results of a randomized trial prevention program. Br J Addict 1992;87:493-8.
2. Friedman SR, Des Jarlais DC, Neaigus A, et al. AIDS and the new drug injector. Nature 1989;339:333-4.
3. Kleinman PH, Goldsmith DS, Friedman SR, Hopkins W, Des Jarlais DC. Knowledge about and behaviors affecting the spread of AIDS: a street survey of intravenous drug users and their associates in New York City. Int J Addict 1990;25:345-61.
4. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad; vol 1. San Francisco: University of California, 1993:265-6 and 281-3.
5. Robles RR, Colón HM, Sahai H, Matos TD, Marrero C, Reyes JC. Behavioral risk factors for human immunodeficiency virus prevalence among intravenous drug users in Puerto Rico. Am J Epidemiol 1992;135:531-40.
6. Iguchi MY, Platt JJ, French J, et al. Correlates of HIV seropositivity among injection drug users not in treatment. J Drug Issues 1992;22:849-66.
7. Nicolosi A, Musicco M, Saracco A, et al. Incidence and risk factors of HIV infection: a prospective study of seronegative drug users from Milan and Northern Italy, 1987-1989. Epidemiology 1990;1:453-9.
8. Vlahov D, Muñoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland. Am J Epidemiol 1990;132:847-56.
9. Sasse H, Salmaso S, Conti S, and the First Drug User Multicenter Study Group. Risk behaviors for HIV-1 infection in Italian drug users: report from a multicenter study. J Acquir Immune Defic Syndr 1989;2:486-96.
10. Chaisson RE, Bacchetti P, Osmond D, Brodie B, Sande MA, Moss AR. Cocaine use and HIV infection in intravenous drug users in San Francisco. JAMA 1989;261:561-5.
11. Nicolosi A, Leite MLC, Musicco M, et al. Parenteral and sexual transmission of human immunodeficiency virus in intravenous drug users: a study of seroconversion. Am J Epidemiol 1992;135:225-33.
12. Nemoto T. Behavioral characteristics of seroconverted intravenous drug users. Int J Addict 1992;27:1413-21.
13. Jose B, Friedman SR, Neaigus A, et al. Syringe-mediated drug-sharing (backloading) : a new risk factor for HIV among injecting drug users. AIDS 1993;7:1653-60.
14. Grand JPC, Friedman SR, Stern LS, et al. Syringe-mediated drug sharing among injecting drug users: patterns, social context and implications for transmission of blood-borne pathogens. Soc Sci Med 1996 (in press).
15. Koester SK, Hoffer L. "Indirect sharing": additional HIV risks associated with drug injection. AIDS Public Policy 1994;Summer:100-5.
16. Neaigus A, Friedman SR, Curtis R, et al. The relevance of drug injectors' social networks and risk networks for understanding and preventing HIV infection. Soc Sci Med 1994;38:67-78.
17. Watters J, Biernacki P. Targeted sampling: options for the study of hidden populations. Soc Probl 1989;36:416-29.
18. Neaigus A, Friedman SR, Goldstein M, Ildefonso G, Curtis R, Jose B. Using dyadic data for a network analysis of HIV infection and risk behaviors among injecting drug users. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:20-37 (NIDA Research Monograph 151).
19. Friedman SR. Summary: promising social network research results and suggestions for a research agenda. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:196-215 (NIDA Research Monograph 151).
20. Friedman SR, Des Jarlais DC, Sotheran JL, Garber J, Cohen H, Smith D. AIDS and self-organization among intravenous drug users. Inter J Addict 1987;22:201-19.
21. Selwyn PA, Feiner C, Cox CP, Lipshutz C, Cohen RL. Knowledge about AIDS and high risk behavior among intravenous drag users in New York City. AIDS 1987;1:247-54.
22. Goldstein MF, Friedman SR, Neaigus A, Jose B, Ildefonso G, Curtis R. Self-reports of HIV risk behaviors by injecting drug users: are they reliable? Addiction 1995;90:1097-104.
23. Marmor M, Des Jarlais DC, Cohen H, et al. Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS 1987;1:39-44.
24. D'Aquila RT, Peterson LR, Williams AB, William AE. Race/ethnicity as a risk factor for HIV-1 infection among Connecticut intravenous drug users. J Acquir Immune Defic Syndr 1989;2:503-13.
25. Dasgupta S, Friedman SR, Jose B, et al. Using retrospective behavioral data to determine HIV risk factors among street-recruited drug injectors. J Drug Issues 1995;25:161-71.
26. Des Jarlais DC, Friedman SR, Sotheran JL, et al. Continuity and change within an HIV epidemic. JAMA 1994;271:121-7.
27. Morris M, Zavisca J, Dean L. Social and sexual networks: their role in the spread of HIV/AIDS among young gay men. AIDS Educ Prev 1995;7(suppl):24-35.
28. Shade SB, Estilo M, Watters JK. Characteristics and risk behaviors of new drug injectors [Abstract PO-C15-2939]. In: Ninth international conference on AIDS/IV STD world congress, Berlin, June 1993.
29. Ouellet L, Jimenez AD, Wiebel WW. Heroin again: new users of heroin in Chicago. Miami Beach, FL: Society for the Study of Social Problems, 1993.
30. Curtis R, Friedman SR, Neaigus A, Jose B, Goldstein M, Ildefonso G. Emerging patterns of drag use among youth in a neighborhood with high HIV seroprevalence [Abstract 2002]. In: 122nd annual meeting of the American Public Health Association, Washington, DC, November 1994.
31. Friedman SR, Des Jarlais DC, Wenston J, Sotheran JL. Stable racial/ethnic differences in HIV seroprevalence among IDUs [Abstract 285]. In: First National conference on human retroviruses and related infections, Washington, DC, February 1993.
32. Friedman SR, Neaigus A, Jose B, et al. Network and socio-historical approaches to the HIV epidemic among drug injectors. In: Catalan J, Hedge B, Sherr L, eds. PsychoSocial Aspects of AIDS. Chur, Switzerland: Harwood Academic, 1996 (in press).
33. van Ameijden EJC, van den Hoek JAR, Hartgers C, Coutinho RA. Risk factors for the transition from non- injecting to injecting drug use and accompanying AIDS risk behavior in a cohort of drug users. Am J Epidemiol 1994;39: 1153-63.
34. Friedman SR, Jose B, Neaigus A, et al. Consistent condom use in relationships between seropositive injecting drug users and sex partners who did not inject drugs. AIDS 1994;8:357-61.
35. Frey FW, Abrutyn E, Metzger DS, Woody GE, O'Brien CP, Trusiani P. HIV risk and social networks: the close relations of male African-American intravenous drug users (IDUs). In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:89-108 (NIDA Research Monograph 151).
36. Price RK, Cottler LB, Mager D, Murray KS. Injecting drug use, characteristics of significant others, and HIV risk behaviors. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:38-59 (NIDA Research Monograph 151).
37. Trotter II RT, Bowen AM, Potter JM. Network models for HIV outreach and prevention programs for drug users. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:144-80 (NIDA Research Monograph 151).
38. Williams ML, Zhangqing Z, Siegal HA, Robles RR, Trotter II RT, Jones A. A comparison of drug use networks across three cities. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:109-30 (NIDA Research Monograph 151).
39. Friedman SR, Jose B, Deren S, Des Jarlais DC, Neaigus A. Risk factors for human immunodeficiency virus seroconversion among out-of-treatment drug injectors in high and low seroprevalence cities. Am J Epidemiol 1995;142:864-74.
40. Klovdahl AS. Social networks and the spread of infectious diseases: the AIDS example. Soc Sci Med 1985;21:1203-16.
41. Woodhouse DE, Rothenberg RB, Potterat JJ, et al. Mapping a social network of heterosexuals at high risk of HIV infection. AIDS 1994;8:1331-6.
42. Mandell W, Latkin CA, Oziemkowska M, Celentano DD, Vlahov D. Impact of social network intervention on HIV risk behaviors in injecting drug users. In: Annual meeting of the American Psychological Association, San Francisco, August 1993.
43. Latkin CA. A personal network approach to AIDS prevention: an experimental peer group intervention for street-injecting drug users-the SAFE study. In: Needle RH, Genser SG, Trotter II RT, eds. Social networks, drug abuse, and HIV transmission. Rockville, MD: National Institute on Drug Abuse, 1995:181-95 (NIDA Research Monograph 151).
44. Friedman SR, Sufian M, Curtis R, Neaigus A, Des Jarlais DC. Organizing drug users against AIDS. In: Huber J, Schneider BE, eds. The social context of AIDS. Newbury Park, CA: Sage, 1992:115-30.
45. Sufian M, Friedman SR, Curtis R, Neaigus A, Stepherson B. Organizing as a new approach to AIDS risk reduction for intravenous drug users. J Addict Dis 1991;10:89-98.
46. Carlson G, Needle R. Sponsoring addict self-organization (Addicts Against AIDS): a case study. Presented at the First Annual National AIDS Demonstration Research conference, Rockville, MD, 1989.